Le Lézard
Classified in: Health, Business
Subject: JVN

Breg, Inc. and UK/Ireland Distributor Joint Operations LLP Announce new Partnership


CARLSBAD, Calif., July 13, 2020 /PRNewswire/ -- Breg, Inc., a leading orthopedic bracing and billing services company, has partnered with UK-based distributor Joint Operations LLP to expand delivery of its premium, high-value orthopedic products in the UK/Ireland market as of July 1, 2020.

"We conducted an extensive search in the UK to find a distributor that aligns with both our global growth strategy and our company values," said Bianca Flikweert, Breg's International Director of Sales. "Joint Operations had everything we were looking for and more, including a proven track record in orthopedics and the same commitment to enhancing patient care through high-quality products."

Joint Operations provide a comprehensive portfolio of Joint Preservation technologies to the UK and Ireland.  Managing Director Richard Forster said, "Bracing and cold therapy are key elements in the Joint Preservation algorithm and can be combined to great effect with our injection range and surgical platform to correct stability, alignment, cartilage defects and meniscus damage. This partnership will enable Breg and Joint Operations to make the gold standard philosophy of combination treatments widely accessible to the UK and Irish healthcare systems."

The partnership will also include an educational platform to provide eLearning, hands-on training and online consultations for orthopedic practitioners in the UK/Ireland

About Breg

Breg makes orthopedic bracing and devices, but more than that, the company makes durable medical equipment dispensement easier for our customers every step of the way, from hurt to healthy. Breg is committed to supporting practitioners through comprehensive partnerships, supporting patients with high-quality products and services, and delivering seamless support to facilities navigating the complexities of modern healthcare.

As the largest U.S. provider of cold therapy devices and second largest domestic provider of orthopedic bracing, Breg provides products to millions of patients annually. Founded in 1989, Breg is based in Carlsbad, Calif., and is a company of Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry. Visit www.breg.com.

About Joint Operations

Joint Operations was established in 2015 to develop the field of Joint Preservation within the UK and Ireland.  With a strong emphasis on education, the company has grown rapidly and is one of the key participants within its chosen subspecialty.  Visit www.jointoperations.co.uk.

Outside of orthopaedics, the Joint Operations Family has access to the advanced woundcare, neurosurgery and spinal markets via sister companies Regen Medical and Joint Operations Spine.

 

SOURCE Breg, Inc.


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: